nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbinoxamine—CYP2D6—Temsirolimus—kidney cancer	0.0705	0.0904	CbGbCtD
Carbinoxamine—CYP3A4—Everolimus—kidney cancer	0.0663	0.0851	CbGbCtD
Carbinoxamine—CYP2C8—Pazopanib—kidney cancer	0.058	0.0745	CbGbCtD
Carbinoxamine—CYP3A4—Temsirolimus—kidney cancer	0.0448	0.0575	CbGbCtD
Carbinoxamine—CYP2B6—Sorafenib—kidney cancer	0.0445	0.0571	CbGbCtD
Carbinoxamine—CYP2C9—Capecitabine—kidney cancer	0.0422	0.0542	CbGbCtD
Carbinoxamine—CYP2C8—Erlotinib—kidney cancer	0.0414	0.0532	CbGbCtD
Carbinoxamine—CYP2C8—Paclitaxel—kidney cancer	0.0379	0.0487	CbGbCtD
Carbinoxamine—CYP2D6—Pazopanib—kidney cancer	0.037	0.0475	CbGbCtD
Carbinoxamine—CYP2C8—Sorafenib—kidney cancer	0.0337	0.0432	CbGbCtD
Carbinoxamine—CYP2C19—Sorafenib—kidney cancer	0.0282	0.0363	CbGbCtD
Carbinoxamine—CYP2B6—Doxorubicin—kidney cancer	0.027	0.0346	CbGbCtD
Carbinoxamine—CYP2C9—Paclitaxel—kidney cancer	0.0264	0.0339	CbGbCtD
Carbinoxamine—CYP2D6—Erlotinib—kidney cancer	0.0264	0.0339	CbGbCtD
Carbinoxamine—CYP3A4—Pazopanib—kidney cancer	0.0235	0.0302	CbGbCtD
Carbinoxamine—CYP2C9—Sorafenib—kidney cancer	0.0235	0.0301	CbGbCtD
Carbinoxamine—CYP2D6—Sorafenib—kidney cancer	0.0215	0.0276	CbGbCtD
Carbinoxamine—CYP2D6—Vinblastine—kidney cancer	0.0212	0.0272	CbGbCtD
Carbinoxamine—CYP3A4—Erlotinib—kidney cancer	0.0168	0.0216	CbGbCtD
Carbinoxamine—CYP3A4—Paclitaxel—kidney cancer	0.0154	0.0197	CbGbCtD
Carbinoxamine—CYP3A4—Sorafenib—kidney cancer	0.0137	0.0175	CbGbCtD
Carbinoxamine—CYP3A4—Vinblastine—kidney cancer	0.0135	0.0173	CbGbCtD
Carbinoxamine—CYP3A4—Vincristine—kidney cancer	0.0133	0.017	CbGbCtD
Carbinoxamine—CYP2D6—Doxorubicin—kidney cancer	0.013	0.0167	CbGbCtD
Carbinoxamine—CYP3A4—Sunitinib—kidney cancer	0.0111	0.0142	CbGbCtD
Carbinoxamine—CYP3A4—Doxorubicin—kidney cancer	0.00829	0.0106	CbGbCtD
Carbinoxamine—CYP2C19—urine—kidney cancer	0.00383	0.163	CbGeAlD
Carbinoxamine—CYP2C9—urine—kidney cancer	0.00297	0.126	CbGeAlD
Carbinoxamine—CYP2E1—urine—kidney cancer	0.00282	0.12	CbGeAlD
Carbinoxamine—CYP3A4—urine—kidney cancer	0.00227	0.0962	CbGeAlD
Carbinoxamine—CYP2D6—urine—kidney cancer	0.00223	0.0946	CbGeAlD
Carbinoxamine—CYP2C8—renal system—kidney cancer	0.000819	0.0347	CbGeAlD
Carbinoxamine—CYP2B6—nephron tubule—kidney cancer	0.000808	0.0343	CbGeAlD
Carbinoxamine—CYP2C8—kidney—kidney cancer	0.000792	0.0336	CbGeAlD
Carbinoxamine—Agitation—Everolimus—kidney cancer	0.000763	0.0047	CcSEcCtD
Carbinoxamine—Somnolence—Pazopanib—kidney cancer	0.000763	0.0047	CcSEcCtD
Carbinoxamine—CYP2E1—nephron tubule—kidney cancer	0.000758	0.0322	CbGeAlD
Carbinoxamine—Dyspepsia—Pazopanib—kidney cancer	0.000756	0.00466	CcSEcCtD
Carbinoxamine—Neuritis—Doxorubicin—kidney cancer	0.000755	0.00465	CcSEcCtD
Carbinoxamine—Vertigo—Vinblastine—kidney cancer	0.000749	0.00461	CcSEcCtD
Carbinoxamine—Decreased appetite—Pazopanib—kidney cancer	0.000746	0.0046	CcSEcCtD
Carbinoxamine—Fatigue—Pazopanib—kidney cancer	0.00074	0.00456	CcSEcCtD
Carbinoxamine—Neuropathy peripheral—Vincristine—kidney cancer	0.000736	0.00453	CcSEcCtD
Carbinoxamine—CYP2B6—renal system—kidney cancer	0.000734	0.0312	CbGeAlD
Carbinoxamine—Palpitations—Everolimus—kidney cancer	0.000734	0.00452	CcSEcCtD
Carbinoxamine—Photosensitivity—Capecitabine—kidney cancer	0.000723	0.00446	CcSEcCtD
Carbinoxamine—Convulsion—Vinblastine—kidney cancer	0.000722	0.00445	CcSEcCtD
Carbinoxamine—Convulsion—Everolimus—kidney cancer	0.00072	0.00443	CcSEcCtD
Carbinoxamine—Chills—Sunitinib—kidney cancer	0.000715	0.00441	CcSEcCtD
Carbinoxamine—CYP2B6—kidney—kidney cancer	0.00071	0.0301	CbGeAlD
Carbinoxamine—Haemolytic anaemia—Capecitabine—kidney cancer	0.000703	0.00433	CcSEcCtD
Carbinoxamine—Neuropathy peripheral—Gemcitabine—kidney cancer	0.000698	0.0043	CcSEcCtD
Carbinoxamine—CYP2E1—renal system—kidney cancer	0.000689	0.0292	CbGeAlD
Carbinoxamine—Chills—Dactinomycin—kidney cancer	0.000677	0.00417	CcSEcCtD
Carbinoxamine—CYP2E1—kidney—kidney cancer	0.000666	0.0283	CbGeAlD
Carbinoxamine—Thrombocytopenia—Vinblastine—kidney cancer	0.000666	0.0041	CcSEcCtD
Carbinoxamine—Agranulocytosis—Gemcitabine—kidney cancer	0.000665	0.00409	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Everolimus—kidney cancer	0.000664	0.00409	CcSEcCtD
Carbinoxamine—Tachycardia—Everolimus—kidney cancer	0.000662	0.00408	CcSEcCtD
Carbinoxamine—CYP2B6—gonad—kidney cancer	0.000659	0.0279	CbGeAlD
Carbinoxamine—Hyperhidrosis—Everolimus—kidney cancer	0.000655	0.00404	CcSEcCtD
Carbinoxamine—Asthenia—Temsirolimus—kidney cancer	0.000654	0.00403	CcSEcCtD
Carbinoxamine—Sweating increased—Paclitaxel—kidney cancer	0.000652	0.00401	CcSEcCtD
Carbinoxamine—CYP2E1—cortex of kidney—kidney cancer	0.000649	0.0275	CbGeAlD
Carbinoxamine—Anorexia—Vinblastine—kidney cancer	0.000649	0.004	CcSEcCtD
Carbinoxamine—Anorexia—Everolimus—kidney cancer	0.000646	0.00398	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Erlotinib—kidney cancer	0.00064	0.00394	CcSEcCtD
Carbinoxamine—Diplopia—Capecitabine—kidney cancer	0.000635	0.00391	CcSEcCtD
Carbinoxamine—Hypotension—Everolimus—kidney cancer	0.000633	0.0039	CcSEcCtD
Carbinoxamine—Diarrhoea—Temsirolimus—kidney cancer	0.000623	0.00384	CcSEcCtD
Carbinoxamine—Anorexia—Erlotinib—kidney cancer	0.000623	0.00384	CcSEcCtD
Carbinoxamine—Pollakiuria—Paclitaxel—kidney cancer	0.000618	0.00381	CcSEcCtD
Carbinoxamine—Asthenia—Pazopanib—kidney cancer	0.000616	0.00379	CcSEcCtD
Carbinoxamine—Insomnia—Everolimus—kidney cancer	0.000613	0.00378	CcSEcCtD
Carbinoxamine—Paraesthesia—Vinblastine—kidney cancer	0.000611	0.00376	CcSEcCtD
Carbinoxamine—Photosensitivity reaction—Paclitaxel—kidney cancer	0.00061	0.00376	CcSEcCtD
Carbinoxamine—Paraesthesia—Everolimus—kidney cancer	0.000609	0.00375	CcSEcCtD
Carbinoxamine—Irritability—Capecitabine—kidney cancer	0.000606	0.00373	CcSEcCtD
Carbinoxamine—Urinary retention—Capecitabine—kidney cancer	0.000604	0.00372	CcSEcCtD
Carbinoxamine—Somnolence—Everolimus—kidney cancer	0.000603	0.00371	CcSEcCtD
Carbinoxamine—Dizziness—Temsirolimus—kidney cancer	0.000603	0.00371	CcSEcCtD
Carbinoxamine—Convulsion—Sunitinib—kidney cancer	0.000601	0.0037	CcSEcCtD
Carbinoxamine—Dyspepsia—Everolimus—kidney cancer	0.000597	0.00368	CcSEcCtD
Carbinoxamine—Insomnia—Erlotinib—kidney cancer	0.000592	0.00364	CcSEcCtD
Carbinoxamine—Decreased appetite—Vinblastine—kidney cancer	0.000592	0.00364	CcSEcCtD
Carbinoxamine—Decreased appetite—Everolimus—kidney cancer	0.000589	0.00363	CcSEcCtD
Carbinoxamine—Diarrhoea—Pazopanib—kidney cancer	0.000587	0.00362	CcSEcCtD
Carbinoxamine—Neuropathy peripheral—Paclitaxel—kidney cancer	0.000585	0.0036	CcSEcCtD
Carbinoxamine—Fatigue—Everolimus—kidney cancer	0.000584	0.0036	CcSEcCtD
Carbinoxamine—Constipation—Vinblastine—kidney cancer	0.000582	0.00358	CcSEcCtD
Carbinoxamine—Constipation—Everolimus—kidney cancer	0.00058	0.00357	CcSEcCtD
Carbinoxamine—Vomiting—Temsirolimus—kidney cancer	0.000579	0.00357	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Sorafenib—kidney cancer	0.000576	0.00355	CcSEcCtD
Carbinoxamine—Dyspepsia—Erlotinib—kidney cancer	0.000576	0.00355	CcSEcCtD
Carbinoxamine—Chills—Gemcitabine—kidney cancer	0.000574	0.00353	CcSEcCtD
Carbinoxamine—Headache—Temsirolimus—kidney cancer	0.000571	0.00352	CcSEcCtD
Carbinoxamine—Decreased appetite—Erlotinib—kidney cancer	0.000569	0.0035	CcSEcCtD
Carbinoxamine—Dizziness—Pazopanib—kidney cancer	0.000568	0.0035	CcSEcCtD
Carbinoxamine—Fatigue—Erlotinib—kidney cancer	0.000564	0.00347	CcSEcCtD
Carbinoxamine—Anorexia—Sorafenib—kidney cancer	0.000561	0.00346	CcSEcCtD
Carbinoxamine—Feeling abnormal—Vinblastine—kidney cancer	0.000561	0.00345	CcSEcCtD
Carbinoxamine—Constipation—Erlotinib—kidney cancer	0.000559	0.00345	CcSEcCtD
Carbinoxamine—Feeling abnormal—Everolimus—kidney cancer	0.000559	0.00344	CcSEcCtD
Carbinoxamine—CYP3A4—renal system—kidney cancer	0.000555	0.0235	CbGeAlD
Carbinoxamine—Thrombocytopenia—Sunitinib—kidney cancer	0.000554	0.00342	CcSEcCtD
Carbinoxamine—Vomiting—Pazopanib—kidney cancer	0.000546	0.00336	CcSEcCtD
Carbinoxamine—CYP2D6—renal system—kidney cancer	0.000546	0.0232	CbGeAlD
Carbinoxamine—Nausea—Temsirolimus—kidney cancer	0.000541	0.00333	CcSEcCtD
Carbinoxamine—Anorexia—Sunitinib—kidney cancer	0.00054	0.00332	CcSEcCtD
Carbinoxamine—Agitation—Vincristine—kidney cancer	0.000539	0.00332	CcSEcCtD
Carbinoxamine—Headache—Pazopanib—kidney cancer	0.000538	0.00331	CcSEcCtD
Carbinoxamine—CYP3A4—kidney—kidney cancer	0.000536	0.0227	CbGeAlD
Carbinoxamine—Sweating increased—Capecitabine—kidney cancer	0.000535	0.00329	CcSEcCtD
Carbinoxamine—CYP2D6—kidney—kidney cancer	0.000528	0.0224	CbGeAlD
Carbinoxamine—Vertigo—Vincristine—kidney cancer	0.000527	0.00325	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Dactinomycin—kidney cancer	0.000525	0.00323	CcSEcCtD
Carbinoxamine—Dyspepsia—Sorafenib—kidney cancer	0.000518	0.00319	CcSEcCtD
Carbinoxamine—Insomnia—Sunitinib—kidney cancer	0.000512	0.00315	CcSEcCtD
Carbinoxamine—Decreased appetite—Sorafenib—kidney cancer	0.000511	0.00315	CcSEcCtD
Carbinoxamine—Anorexia—Dactinomycin—kidney cancer	0.000511	0.00315	CcSEcCtD
Carbinoxamine—Nausea—Pazopanib—kidney cancer	0.00051	0.00314	CcSEcCtD
Carbinoxamine—Paraesthesia—Sunitinib—kidney cancer	0.000508	0.00313	CcSEcCtD
Carbinoxamine—Convulsion—Vincristine—kidney cancer	0.000508	0.00313	CcSEcCtD
Carbinoxamine—Fatigue—Sorafenib—kidney cancer	0.000507	0.00313	CcSEcCtD
Carbinoxamine—Constipation—Sorafenib—kidney cancer	0.000503	0.0031	CcSEcCtD
Carbinoxamine—Photosensitivity reaction—Capecitabine—kidney cancer	0.000501	0.00309	CcSEcCtD
Carbinoxamine—Tinnitus—Paclitaxel—kidney cancer	0.000499	0.00308	CcSEcCtD
Carbinoxamine—Dyspepsia—Sunitinib—kidney cancer	0.000498	0.00307	CcSEcCtD
Carbinoxamine—Decreased appetite—Sunitinib—kidney cancer	0.000492	0.00303	CcSEcCtD
Carbinoxamine—Asthenia—Vinblastine—kidney cancer	0.000488	0.00301	CcSEcCtD
Carbinoxamine—Fatigue—Sunitinib—kidney cancer	0.000488	0.00301	CcSEcCtD
Carbinoxamine—Asthenia—Everolimus—kidney cancer	0.000486	0.003	CcSEcCtD
Carbinoxamine—Constipation—Sunitinib—kidney cancer	0.000484	0.00298	CcSEcCtD
Carbinoxamine—Chills—Paclitaxel—kidney cancer	0.00048	0.00296	CcSEcCtD
Carbinoxamine—Neuropathy peripheral—Capecitabine—kidney cancer	0.00048	0.00296	CcSEcCtD
Carbinoxamine—Asthenia—Erlotinib—kidney cancer	0.000469	0.00289	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Vincristine—kidney cancer	0.000469	0.00289	CcSEcCtD
Carbinoxamine—Urticaria—Sorafenib—kidney cancer	0.000467	0.00288	CcSEcCtD
Carbinoxamine—Photosensitivity—Doxorubicin—kidney cancer	0.000466	0.00287	CcSEcCtD
Carbinoxamine—Decreased appetite—Dactinomycin—kidney cancer	0.000466	0.00287	CcSEcCtD
Carbinoxamine—Diarrhoea—Vinblastine—kidney cancer	0.000466	0.00287	CcSEcCtD
Carbinoxamine—Diarrhoea—Everolimus—kidney cancer	0.000464	0.00286	CcSEcCtD
Carbinoxamine—Hyperhidrosis—Vincristine—kidney cancer	0.000463	0.00285	CcSEcCtD
Carbinoxamine—Fatigue—Dactinomycin—kidney cancer	0.000462	0.00285	CcSEcCtD
Carbinoxamine—Tension—Paclitaxel—kidney cancer	0.000457	0.00282	CcSEcCtD
Carbinoxamine—Agranulocytosis—Capecitabine—kidney cancer	0.000457	0.00281	CcSEcCtD
Carbinoxamine—Anorexia—Vincristine—kidney cancer	0.000456	0.00281	CcSEcCtD
Carbinoxamine—Nervousness—Paclitaxel—kidney cancer	0.000453	0.00279	CcSEcCtD
Carbinoxamine—Dizziness—Vinblastine—kidney cancer	0.00045	0.00277	CcSEcCtD
Carbinoxamine—Dizziness—Everolimus—kidney cancer	0.000448	0.00276	CcSEcCtD
Carbinoxamine—Diarrhoea—Erlotinib—kidney cancer	0.000447	0.00276	CcSEcCtD
Carbinoxamine—Hypotension—Vincristine—kidney cancer	0.000447	0.00276	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Gemcitabine—kidney cancer	0.000445	0.00274	CcSEcCtD
Carbinoxamine—Feeling abnormal—Dactinomycin—kidney cancer	0.000442	0.00272	CcSEcCtD
Carbinoxamine—Vision blurred—Paclitaxel—kidney cancer	0.000439	0.00271	CcSEcCtD
Carbinoxamine—Hyperhidrosis—Gemcitabine—kidney cancer	0.000439	0.00271	CcSEcCtD
Carbinoxamine—Tremor—Paclitaxel—kidney cancer	0.000437	0.00269	CcSEcCtD
Carbinoxamine—Insomnia—Vincristine—kidney cancer	0.000433	0.00267	CcSEcCtD
Carbinoxamine—Anorexia—Gemcitabine—kidney cancer	0.000433	0.00267	CcSEcCtD
Carbinoxamine—Vomiting—Vinblastine—kidney cancer	0.000433	0.00267	CcSEcCtD
Carbinoxamine—Dizziness—Erlotinib—kidney cancer	0.000432	0.00266	CcSEcCtD
Carbinoxamine—Vomiting—Everolimus—kidney cancer	0.000431	0.00266	CcSEcCtD
Carbinoxamine—Paraesthesia—Vincristine—kidney cancer	0.00043	0.00265	CcSEcCtD
Carbinoxamine—Agitation—Paclitaxel—kidney cancer	0.000428	0.00264	CcSEcCtD
Carbinoxamine—Headache—Vinblastine—kidney cancer	0.000426	0.00263	CcSEcCtD
Carbinoxamine—Headache—Everolimus—kidney cancer	0.000425	0.00262	CcSEcCtD
Carbinoxamine—Hypotension—Gemcitabine—kidney cancer	0.000424	0.00262	CcSEcCtD
Carbinoxamine—Asthenia—Sorafenib—kidney cancer	0.000422	0.0026	CcSEcCtD
Carbinoxamine—Vertigo—Paclitaxel—kidney cancer	0.000419	0.00258	CcSEcCtD
Carbinoxamine—Decreased appetite—Vincristine—kidney cancer	0.000416	0.00256	CcSEcCtD
Carbinoxamine—Vomiting—Erlotinib—kidney cancer	0.000416	0.00256	CcSEcCtD
Carbinoxamine—Fatigue—Vincristine—kidney cancer	0.000413	0.00254	CcSEcCtD
Carbinoxamine—Palpitations—Paclitaxel—kidney cancer	0.000412	0.00254	CcSEcCtD
Carbinoxamine—Insomnia—Gemcitabine—kidney cancer	0.000411	0.00253	CcSEcCtD
Carbinoxamine—Headache—Erlotinib—kidney cancer	0.00041	0.00252	CcSEcCtD
Carbinoxamine—Tinnitus—Capecitabine—kidney cancer	0.00041	0.00252	CcSEcCtD
Carbinoxamine—Constipation—Vincristine—kidney cancer	0.00041	0.00252	CcSEcCtD
Carbinoxamine—Diplopia—Doxorubicin—kidney cancer	0.000409	0.00252	CcSEcCtD
Carbinoxamine—Paraesthesia—Gemcitabine—kidney cancer	0.000408	0.00251	CcSEcCtD
Carbinoxamine—Asthenia—Sunitinib—kidney cancer	0.000406	0.0025	CcSEcCtD
Carbinoxamine—Nausea—Vinblastine—kidney cancer	0.000404	0.00249	CcSEcCtD
Carbinoxamine—Somnolence—Gemcitabine—kidney cancer	0.000404	0.00249	CcSEcCtD
Carbinoxamine—Convulsion—Paclitaxel—kidney cancer	0.000404	0.00249	CcSEcCtD
Carbinoxamine—Nausea—Everolimus—kidney cancer	0.000403	0.00248	CcSEcCtD
Carbinoxamine—Diarrhoea—Sorafenib—kidney cancer	0.000403	0.00248	CcSEcCtD
Carbinoxamine—Decreased appetite—Gemcitabine—kidney cancer	0.000395	0.00243	CcSEcCtD
Carbinoxamine—Chills—Capecitabine—kidney cancer	0.000394	0.00243	CcSEcCtD
Carbinoxamine—Fatigue—Gemcitabine—kidney cancer	0.000392	0.00241	CcSEcCtD
Carbinoxamine—Dizziness—Sorafenib—kidney cancer	0.000389	0.0024	CcSEcCtD
Carbinoxamine—Constipation—Gemcitabine—kidney cancer	0.000388	0.00239	CcSEcCtD
Carbinoxamine—Nausea—Erlotinib—kidney cancer	0.000388	0.00239	CcSEcCtD
Carbinoxamine—Diarrhoea—Sunitinib—kidney cancer	0.000387	0.00239	CcSEcCtD
Carbinoxamine—Asthenia—Dactinomycin—kidney cancer	0.000385	0.00237	CcSEcCtD
Carbinoxamine—Confusional state—Paclitaxel—kidney cancer	0.000384	0.00236	CcSEcCtD
Carbinoxamine—Dizziness—Sunitinib—kidney cancer	0.000374	0.00231	CcSEcCtD
Carbinoxamine—Feeling abnormal—Gemcitabine—kidney cancer	0.000374	0.00231	CcSEcCtD
Carbinoxamine—Vomiting—Sorafenib—kidney cancer	0.000374	0.0023	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Paclitaxel—kidney cancer	0.000372	0.00229	CcSEcCtD
Carbinoxamine—Tachycardia—Paclitaxel—kidney cancer	0.000371	0.00229	CcSEcCtD
Carbinoxamine—Headache—Sorafenib—kidney cancer	0.000369	0.00227	CcSEcCtD
Carbinoxamine—Hyperhidrosis—Paclitaxel—kidney cancer	0.000368	0.00227	CcSEcCtD
Carbinoxamine—Diarrhoea—Dactinomycin—kidney cancer	0.000367	0.00226	CcSEcCtD
Carbinoxamine—Anorexia—Paclitaxel—kidney cancer	0.000363	0.00223	CcSEcCtD
Carbinoxamine—Vision blurred—Capecitabine—kidney cancer	0.00036	0.00222	CcSEcCtD
Carbinoxamine—Vomiting—Sunitinib—kidney cancer	0.00036	0.00222	CcSEcCtD
Carbinoxamine—Tremor—Capecitabine—kidney cancer	0.000358	0.00221	CcSEcCtD
Carbinoxamine—Hypotension—Paclitaxel—kidney cancer	0.000355	0.00219	CcSEcCtD
Carbinoxamine—Headache—Sunitinib—kidney cancer	0.000355	0.00219	CcSEcCtD
Carbinoxamine—Nausea—Sorafenib—kidney cancer	0.000349	0.00215	CcSEcCtD
Carbinoxamine—Insomnia—Paclitaxel—kidney cancer	0.000344	0.00212	CcSEcCtD
Carbinoxamine—Vertigo—Capecitabine—kidney cancer	0.000344	0.00212	CcSEcCtD
Carbinoxamine—Asthenia—Vincristine—kidney cancer	0.000344	0.00212	CcSEcCtD
Carbinoxamine—Paraesthesia—Paclitaxel—kidney cancer	0.000342	0.0021	CcSEcCtD
Carbinoxamine—Vomiting—Dactinomycin—kidney cancer	0.000341	0.0021	CcSEcCtD
Carbinoxamine—Somnolence—Paclitaxel—kidney cancer	0.000338	0.00208	CcSEcCtD
Carbinoxamine—Palpitations—Capecitabine—kidney cancer	0.000338	0.00208	CcSEcCtD
Carbinoxamine—Nausea—Sunitinib—kidney cancer	0.000336	0.00207	CcSEcCtD
Carbinoxamine—Dyspepsia—Paclitaxel—kidney cancer	0.000335	0.00206	CcSEcCtD
Carbinoxamine—Decreased appetite—Paclitaxel—kidney cancer	0.000331	0.00204	CcSEcCtD
Carbinoxamine—Fatigue—Paclitaxel—kidney cancer	0.000328	0.00202	CcSEcCtD
Carbinoxamine—Diarrhoea—Vincristine—kidney cancer	0.000328	0.00202	CcSEcCtD
Carbinoxamine—Pollakiuria—Doxorubicin—kidney cancer	0.000327	0.00201	CcSEcCtD
Carbinoxamine—Asthenia—Gemcitabine—kidney cancer	0.000326	0.00201	CcSEcCtD
Carbinoxamine—Constipation—Paclitaxel—kidney cancer	0.000325	0.002	CcSEcCtD
Carbinoxamine—Photosensitivity reaction—Doxorubicin—kidney cancer	0.000323	0.00199	CcSEcCtD
Carbinoxamine—Nausea—Dactinomycin—kidney cancer	0.000318	0.00196	CcSEcCtD
Carbinoxamine—Dizziness—Vincristine—kidney cancer	0.000317	0.00195	CcSEcCtD
Carbinoxamine—Drowsiness—Doxorubicin—kidney cancer	0.000315	0.00194	CcSEcCtD
Carbinoxamine—Confusional state—Capecitabine—kidney cancer	0.000315	0.00194	CcSEcCtD
Carbinoxamine—Feeling abnormal—Paclitaxel—kidney cancer	0.000313	0.00193	CcSEcCtD
Carbinoxamine—Diarrhoea—Gemcitabine—kidney cancer	0.000311	0.00191	CcSEcCtD
Carbinoxamine—Neuropathy peripheral—Doxorubicin—kidney cancer	0.000309	0.00191	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Capecitabine—kidney cancer	0.000306	0.00188	CcSEcCtD
Carbinoxamine—Tachycardia—Capecitabine—kidney cancer	0.000305	0.00188	CcSEcCtD
Carbinoxamine—Vomiting—Vincristine—kidney cancer	0.000304	0.00188	CcSEcCtD
Carbinoxamine—Urticaria—Paclitaxel—kidney cancer	0.000302	0.00186	CcSEcCtD
Carbinoxamine—Hyperhidrosis—Capecitabine—kidney cancer	0.000302	0.00186	CcSEcCtD
Carbinoxamine—Headache—Vincristine—kidney cancer	0.0003	0.00185	CcSEcCtD
Carbinoxamine—Anorexia—Capecitabine—kidney cancer	0.000298	0.00183	CcSEcCtD
Carbinoxamine—Agranulocytosis—Doxorubicin—kidney cancer	0.000294	0.00181	CcSEcCtD
Carbinoxamine—Hypotension—Capecitabine—kidney cancer	0.000292	0.0018	CcSEcCtD
Carbinoxamine—Vomiting—Gemcitabine—kidney cancer	0.000289	0.00178	CcSEcCtD
Carbinoxamine—Headache—Gemcitabine—kidney cancer	0.000285	0.00175	CcSEcCtD
Carbinoxamine—Nausea—Vincristine—kidney cancer	0.000284	0.00175	CcSEcCtD
Carbinoxamine—Insomnia—Capecitabine—kidney cancer	0.000282	0.00174	CcSEcCtD
Carbinoxamine—Paraesthesia—Capecitabine—kidney cancer	0.00028	0.00173	CcSEcCtD
Carbinoxamine—Dyspepsia—Capecitabine—kidney cancer	0.000275	0.00169	CcSEcCtD
Carbinoxamine—Asthenia—Paclitaxel—kidney cancer	0.000273	0.00168	CcSEcCtD
Carbinoxamine—Decreased appetite—Capecitabine—kidney cancer	0.000271	0.00167	CcSEcCtD
Carbinoxamine—Nausea—Gemcitabine—kidney cancer	0.00027	0.00166	CcSEcCtD
Carbinoxamine—Fatigue—Capecitabine—kidney cancer	0.000269	0.00166	CcSEcCtD
Carbinoxamine—Constipation—Capecitabine—kidney cancer	0.000267	0.00164	CcSEcCtD
Carbinoxamine—Tinnitus—Doxorubicin—kidney cancer	0.000264	0.00163	CcSEcCtD
Carbinoxamine—Diarrhoea—Paclitaxel—kidney cancer	0.00026	0.0016	CcSEcCtD
Carbinoxamine—Feeling abnormal—Capecitabine—kidney cancer	0.000257	0.00158	CcSEcCtD
Carbinoxamine—Chills—Doxorubicin—kidney cancer	0.000254	0.00157	CcSEcCtD
Carbinoxamine—Dizziness—Paclitaxel—kidney cancer	0.000252	0.00155	CcSEcCtD
Carbinoxamine—Urticaria—Capecitabine—kidney cancer	0.000248	0.00153	CcSEcCtD
Carbinoxamine—Tension—Doxorubicin—kidney cancer	0.000242	0.00149	CcSEcCtD
Carbinoxamine—Vomiting—Paclitaxel—kidney cancer	0.000242	0.00149	CcSEcCtD
Carbinoxamine—Nervousness—Doxorubicin—kidney cancer	0.000239	0.00148	CcSEcCtD
Carbinoxamine—Headache—Paclitaxel—kidney cancer	0.000238	0.00147	CcSEcCtD
Carbinoxamine—Vision blurred—Doxorubicin—kidney cancer	0.000232	0.00143	CcSEcCtD
Carbinoxamine—Agitation—Doxorubicin—kidney cancer	0.000227	0.0014	CcSEcCtD
Carbinoxamine—Nausea—Paclitaxel—kidney cancer	0.000226	0.00139	CcSEcCtD
Carbinoxamine—Asthenia—Capecitabine—kidney cancer	0.000224	0.00138	CcSEcCtD
Carbinoxamine—Vertigo—Doxorubicin—kidney cancer	0.000221	0.00136	CcSEcCtD
Carbinoxamine—Palpitations—Doxorubicin—kidney cancer	0.000218	0.00134	CcSEcCtD
Carbinoxamine—Convulsion—Doxorubicin—kidney cancer	0.000214	0.00132	CcSEcCtD
Carbinoxamine—Diarrhoea—Capecitabine—kidney cancer	0.000214	0.00132	CcSEcCtD
Carbinoxamine—Dizziness—Capecitabine—kidney cancer	0.000206	0.00127	CcSEcCtD
Carbinoxamine—Confusional state—Doxorubicin—kidney cancer	0.000203	0.00125	CcSEcCtD
Carbinoxamine—Vomiting—Capecitabine—kidney cancer	0.000198	0.00122	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Doxorubicin—kidney cancer	0.000197	0.00121	CcSEcCtD
Carbinoxamine—Tachycardia—Doxorubicin—kidney cancer	0.000196	0.00121	CcSEcCtD
Carbinoxamine—Headache—Capecitabine—kidney cancer	0.000196	0.0012	CcSEcCtD
Carbinoxamine—Hyperhidrosis—Doxorubicin—kidney cancer	0.000195	0.0012	CcSEcCtD
Carbinoxamine—Clomipramine—GSTP1—kidney cancer	0.000192	0.371	CrCbGaD
Carbinoxamine—Anorexia—Doxorubicin—kidney cancer	0.000192	0.00118	CcSEcCtD
Carbinoxamine—Hypotension—Doxorubicin—kidney cancer	0.000188	0.00116	CcSEcCtD
Carbinoxamine—Nausea—Capecitabine—kidney cancer	0.000185	0.00114	CcSEcCtD
Carbinoxamine—Insomnia—Doxorubicin—kidney cancer	0.000182	0.00112	CcSEcCtD
Carbinoxamine—Paraesthesia—Doxorubicin—kidney cancer	0.000181	0.00111	CcSEcCtD
Carbinoxamine—Somnolence—Doxorubicin—kidney cancer	0.000179	0.0011	CcSEcCtD
Carbinoxamine—Dyspepsia—Doxorubicin—kidney cancer	0.000177	0.00109	CcSEcCtD
Carbinoxamine—Decreased appetite—Doxorubicin—kidney cancer	0.000175	0.00108	CcSEcCtD
Carbinoxamine—Fatigue—Doxorubicin—kidney cancer	0.000173	0.00107	CcSEcCtD
Carbinoxamine—Constipation—Doxorubicin—kidney cancer	0.000172	0.00106	CcSEcCtD
Carbinoxamine—Feeling abnormal—Doxorubicin—kidney cancer	0.000166	0.00102	CcSEcCtD
Carbinoxamine—Urticaria—Doxorubicin—kidney cancer	0.00016	0.000985	CcSEcCtD
Carbinoxamine—Asthenia—Doxorubicin—kidney cancer	0.000144	0.000889	CcSEcCtD
Carbinoxamine—Diarrhoea—Doxorubicin—kidney cancer	0.000138	0.000848	CcSEcCtD
Carbinoxamine—Dizziness—Doxorubicin—kidney cancer	0.000133	0.00082	CcSEcCtD
Carbinoxamine—Vomiting—Doxorubicin—kidney cancer	0.000128	0.000788	CcSEcCtD
Carbinoxamine—Headache—Doxorubicin—kidney cancer	0.000126	0.000777	CcSEcCtD
Carbinoxamine—Nausea—Doxorubicin—kidney cancer	0.00012	0.000736	CcSEcCtD
Carbinoxamine—Diphenhydramine—PTGS1—kidney cancer	9.62e-05	0.186	CrCbGaD
Carbinoxamine—Chlorpromazine—BCHE—kidney cancer	9.06e-05	0.175	CrCbGaD
Carbinoxamine—Clomipramine—ABCB1—kidney cancer	5.18e-05	0.0999	CrCbGaD
Carbinoxamine—Chlorprothixene—ABCB1—kidney cancer	5.15e-05	0.0995	CrCbGaD
Carbinoxamine—Chlorpromazine—ABCB1—kidney cancer	3.55e-05	0.0685	CrCbGaD
Carbinoxamine—CYP2C8—Metabolism—ALDH1A1—kidney cancer	2.05e-05	0.000593	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—GPC3—kidney cancer	2.02e-05	0.000585	CbGpPWpGaD
Carbinoxamine—HRH1—G alpha (q) signalling events—PIK3CA—kidney cancer	2.01e-05	0.000582	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—ACY1—kidney cancer	2.01e-05	0.000581	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—FH—kidney cancer	1.98e-05	0.000573	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—APRT—kidney cancer	1.98e-05	0.000573	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—CA9—kidney cancer	1.97e-05	0.000571	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—CA2—kidney cancer	1.97e-05	0.000569	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—PGK1—kidney cancer	1.96e-05	0.000569	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—SLC5A3—kidney cancer	1.96e-05	0.000569	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—APRT—kidney cancer	1.96e-05	0.000568	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—FH—kidney cancer	1.96e-05	0.000568	CbGpPWpGaD
Carbinoxamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—kidney cancer	1.96e-05	0.000566	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—CA9—kidney cancer	1.93e-05	0.000559	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—LDHB—kidney cancer	1.92e-05	0.000558	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—ALAD—kidney cancer	1.92e-05	0.000555	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	1.92e-05	0.000555	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—ST3GAL2—kidney cancer	1.87e-05	0.000542	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—GPC3—kidney cancer	1.86e-05	0.000538	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—GPC3—kidney cancer	1.84e-05	0.000534	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—ALDH1A1—kidney cancer	1.83e-05	0.000529	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—CA2—kidney cancer	1.81e-05	0.000524	CbGpPWpGaD
Carbinoxamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—kidney cancer	1.8e-05	0.00052	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—CASP2—kidney cancer	1.79e-05	0.000519	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—AKAP13—kidney cancer	1.79e-05	0.000519	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—CA2—kidney cancer	1.79e-05	0.000519	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—ALAD—kidney cancer	1.76e-05	0.00051	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—PGK1—kidney cancer	1.75e-05	0.000507	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—SLC5A3—kidney cancer	1.75e-05	0.000507	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—ALAD—kidney cancer	1.75e-05	0.000506	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—ST3GAL2—kidney cancer	1.72e-05	0.000498	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—LDHB—kidney cancer	1.72e-05	0.000498	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—PDHB—kidney cancer	1.71e-05	0.000494	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—ST3GAL2—kidney cancer	1.7e-05	0.000494	CbGpPWpGaD
Carbinoxamine—CYP3A4—Biological oxidations—POMC—kidney cancer	1.7e-05	0.000492	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—ALDH1A1—kidney cancer	1.68e-05	0.000487	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—CRABP1—kidney cancer	1.68e-05	0.000486	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—CA9—kidney cancer	1.67e-05	0.000483	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—ALDH1A1—kidney cancer	1.67e-05	0.000483	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—CRABP1—kidney cancer	1.64e-05	0.000476	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—GRB7—kidney cancer	1.64e-05	0.000475	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.63e-05	0.000472	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—PGK1—kidney cancer	1.61e-05	0.000467	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—SLC5A3—kidney cancer	1.61e-05	0.000467	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—CCBL1—kidney cancer	1.6e-05	0.000464	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—SLC5A3—kidney cancer	1.6e-05	0.000463	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—PGK1—kidney cancer	1.6e-05	0.000463	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—LDHB—kidney cancer	1.58e-05	0.000458	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—LDHB—kidney cancer	1.57e-05	0.000454	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—ITPR2—kidney cancer	1.56e-05	0.000451	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—ITPR2—kidney cancer	1.53e-05	0.000442	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—ITPR2—kidney cancer	1.52e-05	0.000442	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—CA9—kidney cancer	1.49e-05	0.000431	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.46e-05	0.000422	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—GSTT1—kidney cancer	1.42e-05	0.000412	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—ACHE—kidney cancer	1.42e-05	0.000412	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—CRABP1—kidney cancer	1.42e-05	0.000411	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—ACHE—kidney cancer	1.39e-05	0.000403	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—GSTT1—kidney cancer	1.39e-05	0.000403	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—PPAT—kidney cancer	1.39e-05	0.000403	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—GLIPR1—kidney cancer	1.39e-05	0.000403	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—CTNNA1—kidney cancer	1.38e-05	0.0004	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—EIF4EBP1—kidney cancer	1.37e-05	0.000398	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—HSPB1—kidney cancer	1.37e-05	0.000398	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—CA9—kidney cancer	1.37e-05	0.000397	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—CA9—kidney cancer	1.36e-05	0.000393	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—SCARB1—kidney cancer	1.35e-05	0.00039	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—PTGS1—kidney cancer	1.33e-05	0.000386	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.33e-05	0.000385	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—ITPR2—kidney cancer	1.32e-05	0.000382	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—SCARB1—kidney cancer	1.32e-05	0.000382	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—PSMD7—kidney cancer	1.31e-05	0.000378	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—PTGS1—kidney cancer	1.3e-05	0.000378	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—FH—kidney cancer	1.29e-05	0.000374	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—APRT—kidney cancer	1.29e-05	0.000374	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—PSMD7—kidney cancer	1.28e-05	0.00037	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—ANXA1—kidney cancer	1.28e-05	0.00037	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—TSC1—kidney cancer	1.28e-05	0.00037	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—PSMD7—kidney cancer	1.28e-05	0.00037	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—CRABP1—kidney cancer	1.27e-05	0.000367	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—BCHE—kidney cancer	1.24e-05	0.000359	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—FLT1—kidney cancer	1.24e-05	0.000358	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—SLC5A5—kidney cancer	1.22e-05	0.000354	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.22e-05	0.000352	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—GPC3—kidney cancer	1.22e-05	0.000352	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—BCHE—kidney cancer	1.21e-05	0.000351	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—GSTT1—kidney cancer	1.2e-05	0.000348	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—ACHE—kidney cancer	1.2e-05	0.000348	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—SLC5A5—kidney cancer	1.2e-05	0.000347	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—CA2—kidney cancer	1.18e-05	0.000342	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—SLC2A1—kidney cancer	1.18e-05	0.000342	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—ITPR2—kidney cancer	1.18e-05	0.000341	CbGpPWpGaD
Carbinoxamine—HRH1—GPCR downstream signaling—POMC—kidney cancer	1.17e-05	0.000338	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—CRABP1—kidney cancer	1.16e-05	0.000337	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—SLC2A1—kidney cancer	1.16e-05	0.000335	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—CRABP1—kidney cancer	1.15e-05	0.000335	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—ALAD—kidney cancer	1.15e-05	0.000334	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—PAK1—kidney cancer	1.15e-05	0.000332	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—JUNB—kidney cancer	1.15e-05	0.000332	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—SCARB1—kidney cancer	1.14e-05	0.00033	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—PTGS1—kidney cancer	1.13e-05	0.000327	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—ST3GAL2—kidney cancer	1.12e-05	0.000326	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—PSMD7—kidney cancer	1.11e-05	0.00032	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—ALDH1A1—kidney cancer	1.1e-05	0.000318	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.09e-05	0.000314	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—ITPR2—kidney cancer	1.08e-05	0.000314	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—ACHE—kidney cancer	1.07e-05	0.000311	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—GSTT1—kidney cancer	1.07e-05	0.000311	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—ITPR2—kidney cancer	1.07e-05	0.000311	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—POMC—kidney cancer	1.06e-05	0.000307	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—SLC5A3—kidney cancer	1.05e-05	0.000305	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—PGK1—kidney cancer	1.05e-05	0.000305	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—BCHE—kidney cancer	1.05e-05	0.000304	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—SLC5A5—kidney cancer	1.04e-05	0.0003	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—LDHB—kidney cancer	1.03e-05	0.000299	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—SCARB1—kidney cancer	1.02e-05	0.000294	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—PTGS1—kidney cancer	1.01e-05	0.000291	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—SLC2A1—kidney cancer	1e-05	0.00029	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	9.9e-06	0.000287	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—ACHE—kidney cancer	9.88e-06	0.000286	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—GSTT1—kidney cancer	9.88e-06	0.000286	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—PSMD7—kidney cancer	9.87e-06	0.000286	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—GSTP1—kidney cancer	9.85e-06	0.000285	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—ACHE—kidney cancer	9.79e-06	0.000284	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—GSTT1—kidney cancer	9.79e-06	0.000284	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	9.7e-06	0.000281	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—GSTP1—kidney cancer	9.65e-06	0.000279	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—IGF2—kidney cancer	9.38e-06	0.000272	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—BCHE—kidney cancer	9.35e-06	0.000271	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—SCARB1—kidney cancer	9.35e-06	0.000271	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—CDKN2B—kidney cancer	9.33e-06	0.00027	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—ABCB1—kidney cancer	9.32e-06	0.00027	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—SCARB1—kidney cancer	9.27e-06	0.000268	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—PTGS1—kidney cancer	9.25e-06	0.000268	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—SLC5A5—kidney cancer	9.24e-06	0.000268	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—PTGS1—kidney cancer	9.17e-06	0.000266	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—ABCB1—kidney cancer	9.13e-06	0.000265	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—PSMD7—kidney cancer	9.08e-06	0.000263	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—IGF1R—kidney cancer	9.06e-06	0.000263	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—GSTM1—kidney cancer	9.05e-06	0.000262	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—PSMD7—kidney cancer	9e-06	0.000261	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—CA9—kidney cancer	8.96e-06	0.000259	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—SLC2A1—kidney cancer	8.92e-06	0.000258	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—GSTM1—kidney cancer	8.87e-06	0.000257	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—RAF1—kidney cancer	8.73e-06	0.000253	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	8.66e-06	0.000251	CbGpPWpGaD
Carbinoxamine—HRH1—GPCR downstream signaling—IL2—kidney cancer	8.62e-06	0.00025	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—BCHE—kidney cancer	8.6e-06	0.000249	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—CYP1A1—kidney cancer	8.58e-06	0.000249	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—BCHE—kidney cancer	8.53e-06	0.000247	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—SLC5A5—kidney cancer	8.5e-06	0.000246	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	8.46e-06	0.000245	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—SLC5A5—kidney cancer	8.43e-06	0.000244	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—CYP1A1—kidney cancer	8.4e-06	0.000243	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—GSTP1—kidney cancer	8.34e-06	0.000242	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—SLC2A1—kidney cancer	8.21e-06	0.000238	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—SLC2A1—kidney cancer	8.14e-06	0.000236	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	7.89e-06	0.000229	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—ABCB1—kidney cancer	7.89e-06	0.000229	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—IL2—kidney cancer	7.83e-06	0.000227	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—GSTM1—kidney cancer	7.66e-06	0.000222	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—CRABP1—kidney cancer	7.62e-06	0.000221	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	7.55e-06	0.000219	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—HIF1A—kidney cancer	7.46e-06	0.000216	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—TSC2—kidney cancer	7.44e-06	0.000216	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—GSTP1—kidney cancer	7.44e-06	0.000216	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—CYP1A1—kidney cancer	7.26e-06	0.00021	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—KDR—kidney cancer	7.14e-06	0.000207	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—ITPR2—kidney cancer	7.08e-06	0.000205	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—ABCB1—kidney cancer	7.05e-06	0.000204	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	6.88e-06	0.000199	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—GSTP1—kidney cancer	6.85e-06	0.000198	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—GSTM1—kidney cancer	6.84e-06	0.000198	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—GSTP1—kidney cancer	6.79e-06	0.000197	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—KIT—kidney cancer	6.57e-06	0.00019	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—APC—kidney cancer	6.57e-06	0.00019	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—CYP1A1—kidney cancer	6.48e-06	0.000188	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—ABCB1—kidney cancer	6.48e-06	0.000188	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—GSTT1—kidney cancer	6.46e-06	0.000187	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—ACHE—kidney cancer	6.46e-06	0.000187	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—ABCB1—kidney cancer	6.42e-06	0.000186	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—POMC—kidney cancer	6.4e-06	0.000185	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—MAPK3—kidney cancer	6.3e-06	0.000182	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—GSTM1—kidney cancer	6.29e-06	0.000182	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—POMC—kidney cancer	6.27e-06	0.000182	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—POMC—kidney cancer	6.26e-06	0.000181	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—GSTM1—kidney cancer	6.24e-06	0.000181	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—BRAF—kidney cancer	6.18e-06	0.000179	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—SCARB1—kidney cancer	6.11e-06	0.000177	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—PTGS1—kidney cancer	6.05e-06	0.000175	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—MAPK1—kidney cancer	5.99e-06	0.000174	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	5.97e-06	0.000173	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—CYP1A1—kidney cancer	5.96e-06	0.000173	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—PSMD7—kidney cancer	5.93e-06	0.000172	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—CYP1A1—kidney cancer	5.91e-06	0.000171	CbGpPWpGaD
Carbinoxamine—HRH1—GPCR downstream signaling—PIK3CA—kidney cancer	5.72e-06	0.000166	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—KRAS—kidney cancer	5.66e-06	0.000164	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—BCHE—kidney cancer	5.63e-06	0.000163	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—SLC5A5—kidney cancer	5.56e-06	0.000161	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—POMC—kidney cancer	5.42e-06	0.000157	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—SLC2A1—kidney cancer	5.37e-06	0.000155	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	5.33e-06	0.000154	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—PIK3CA—kidney cancer	5.2e-06	0.000151	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—RAF1—kidney cancer	5.16e-06	0.000149	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—RELA—kidney cancer	5.14e-06	0.000149	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—ERBB2—kidney cancer	5.1e-06	0.000148	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—PTGS2—kidney cancer	5.1e-06	0.000148	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—MTOR—kidney cancer	5.04e-06	0.000146	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—PTGS2—kidney cancer	5e-06	0.000145	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	4.86e-06	0.000141	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—POMC—kidney cancer	4.83e-06	0.00014	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—CDKN1B—kidney cancer	4.73e-06	0.000137	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—IL2—kidney cancer	4.63e-06	0.000134	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—CCND1—kidney cancer	4.51e-06	0.000131	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—JUN—kidney cancer	4.5e-06	0.00013	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—GSTP1—kidney cancer	4.48e-06	0.00013	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—CTNNB1—kidney cancer	4.47e-06	0.000129	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—PTEN—kidney cancer	4.45e-06	0.000129	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—POMC—kidney cancer	4.45e-06	0.000129	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—POMC—kidney cancer	4.41e-06	0.000128	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—PTEN—kidney cancer	4.36e-06	0.000126	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—PTEN—kidney cancer	4.35e-06	0.000126	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—PTGS2—kidney cancer	4.32e-06	0.000125	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—ABCB1—kidney cancer	4.24e-06	0.000123	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—GSTM1—kidney cancer	4.11e-06	0.000119	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—VEGFA—kidney cancer	3.93e-06	0.000114	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—CYP1A1—kidney cancer	3.9e-06	0.000113	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—PTGS2—kidney cancer	3.86e-06	0.000112	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—PTEN—kidney cancer	3.77e-06	0.000109	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—MAPK3—kidney cancer	3.72e-06	0.000108	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—MYC—kidney cancer	3.62e-06	0.000105	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—PTGS2—kidney cancer	3.55e-06	0.000103	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—MAPK1—kidney cancer	3.54e-06	0.000103	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—PTGS2—kidney cancer	3.52e-06	0.000102	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—PTEN—kidney cancer	3.36e-06	9.74e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—KRAS—kidney cancer	3.34e-06	9.68e-05	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—PIK3CA—kidney cancer	3.14e-06	9.09e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—PTEN—kidney cancer	3.09e-06	8.96e-05	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—PIK3CA—kidney cancer	3.07e-06	8.91e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—PIK3CA—kidney cancer	3.07e-06	8.9e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—PTEN—kidney cancer	3.07e-06	8.88e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—TP53—kidney cancer	2.97e-06	8.61e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—POMC—kidney cancer	2.91e-06	8.42e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—PIK3CA—kidney cancer	2.66e-06	7.7e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—PIK3CA—kidney cancer	2.37e-06	6.87e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—PTGS2—kidney cancer	2.32e-06	6.72e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—PIK3CA—kidney cancer	2.18e-06	6.32e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—PIK3CA—kidney cancer	2.16e-06	6.27e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—PTEN—kidney cancer	2.02e-06	5.86e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—PIK3CA—kidney cancer	1.43e-06	4.13e-05	CbGpPWpGaD
